Home » Beiträge » 11265

View Beitrag #11265

ID	11265
Ident	[ApoInsights10/24] Moderna Spikevax (PS) [Frei!]
Titel	COVID-19: Der Herbst bringt gute Neuigkeiten
Balkentitel	MODERNA INFORMIERT
Created	2024-11-05 12:45:47
Veraltet	0
typ_id	Universal 2023
sub_typ_id	Eigenbeitrag
html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:5px;padding-top:5px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:25px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">COVID-19: Der Herbst bringt gute Neuigkeiten</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Spikevax<sup style="line-height:0;">®</sup> JN.1</b> ist in einer 50-µg-Fertigspritze verfügbar und ab sofort in der Arzt- und Apothekensoftware hinterlegt. In der praktischen 1er-Packung kann diese mit der PZN 19392072 auf Privatrezept verordnet und bestellt werden.<sup style="line-height:0;">1</sup> </p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#005ca9">Quick Facts zu Spikevax<sup style="line-height:0;">®</sup> JN.1:</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px;"> <ul> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">In der Fertigspritze verfügbar<sup style="line-height:0;">1</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Angepasst an die SARS-CoV-2-Variante JN.1<sup style="line-height:0;">1</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">24 h Verwendbarkeit bei 8 °C bis 25 °C<sup style="line-height:0;">1,#</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Höchstdosierter mRNA-Impfstoff<sup style="line-height:0;">1,2</sup></li> </ul> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#005ca9">Schützen Sie Ihre Risikopatientinnen und Risikopatienten vor schweren Verläufen.</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Die STIKO empfiehlt die Auffrischimpfung insbesondere für ältere Menschen und Hochrisikogruppen.<sup style="line-height:0;">2</sup></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#005ca9">Die Vorteile einer Fertigspritze gegenüber einem Mehrfachdosis-Vial:</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <ul> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Hohe Flexibilität</b> in der Terminvergabe.<sup style="line-height:0;">1,</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Erhebliche Zeitersparnis</b> beim Impfvorgang.<sup style="line-height:0;">1,3,</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Reduzierung von Anwendungsfehlern</b> bei der Dosierung.<sup style="line-height:0;">1,3,</sup></li> </ul> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><img alt="" style="display:block;border:0;outline:none;text-decoration:none" src="https://www.deutschesapothekenportal.de/newsletter/2024q3/newsletter_2024-09-27_g1.jpg"></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Bitte konsultieren Sie vor der Verabreichung die <b>Spikevax<sup style="line-height:0;">®</sup> JN.1</b> Fachinformation:</p> </td> </tr> <tr> <td align="center" style="Margin:0; padding: 20px 20px 20px 20px;"> <table role="presentation" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a href="https://track.adform.net/C/?bn=76326168" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Zur Fachinformation<br></a> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px"># Nach Entnahme aus der Kühlung<br> Eine Impfdosis pro Fertigspritze </p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:5px;padding-bottom:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px"> <b>Referenzen:</b><br> 1 Fachinformation Spikevax<sup style="line-height:0;">®</sup> JN.1 [Internet]. 2024 [zitiert 11. September 2024]. Verfügbar unter: <a href="https://assets.modernatx.com/spikevax-jn.1-smpc-de.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;color:#005CA9;word-break:break-all;">https://assets.modernatx.com/spikevax-jn.1-smpc-de.pdf</a><br> 2 Robert Koch-Institut (RKI). Epidemiologisches Bulletin 02/2024 [Internet]. 2024 [zitiert 28. August 2024]. Verfügbar unter: <a href="https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/02_24.pdf?__blob=publicationFile" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;color:#005CA9;word-break:break-all;">https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/02_24.pdf?__blob=publicationFile</a><br> 3 Eijsink JFH, Weiss M, Taneja A, et al. Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting. Eur J Hosp Pharm. 27.06.2023 [zitiert 28. August 2024]. Verfügbar unter: <a href="https://ejhp.bmj.com/content/ejhpharm/early/2023/06/27/ejhpharm-2022-003620.full.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;color:#005CA9;word-break:break-all;">https://ejhp.bmj.com/content/ejhpharm/early/2023/06/27/ejhpharm-2022-003620.full.pdf</a> </p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:5px;padding-bottom:25px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">DE-COV-2400036</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Typo3Html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px;border-width:0" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-width:0;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="right" style="padding:0;Margin:0;padding-bottom:5px;padding-top:5px;padding-right:0;padding-left:20px;background-color: #e0e0e0;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:18px;letter-spacing:0;color:#777777;font-size:12px !important;"><span style="background:transparent">Anzeige</span></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:25px;padding-bottom:0px"> <h2 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:20px;font-style:normal;font-weight:bold;line-height:24px;color:#005CA9">COVID-19: Der Herbst bringt gute Neuigkeiten</h2> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Spikevax<sup style="line-height:0;">®</sup> JN.1</b> ist in einer 50-µg-Fertigspritze verfügbar und ab sofort in der Arzt- und Apothekensoftware hinterlegt. In der praktischen 1er-Packung kann diese mit der PZN 19392072 auf Privatrezept verordnet und bestellt werden.<sup style="line-height:0;">1</sup> </p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#005ca9">Quick Facts zu Spikevax<sup style="line-height:0;">®</sup> JN.1:</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:5px;"> <ul> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">In der Fertigspritze verfügbar<sup style="line-height:0;">1</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Angepasst an die SARS-CoV-2-Variante JN.1<sup style="line-height:0;">1</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">24 h Verwendbarkeit bei 8 °C bis 25 °C<sup style="line-height:0;">1,#</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Höchstdosierter mRNA-Impfstoff<sup style="line-height:0;">1,2</sup></li> </ul> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#005ca9">Schützen Sie Ihre Risikopatientinnen und Risikopatienten vor schweren Verläufen.</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Die STIKO empfiehlt die Auffrischimpfung insbesondere für ältere Menschen und Hochrisikogruppen.<sup style="line-height:0;">2</sup></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:20px;padding-bottom:0px"> <h3 style="Margin:0;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;mso-line-height-rule:exactly;letter-spacing:0;font-size:14px;font-style:normal;font-weight:bold;line-height:18px;color:#005ca9">Die Vorteile einer Fertigspritze gegenüber einem Mehrfachdosis-Vial:</h3> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:10px"> <ul> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Hohe Flexibilität</b> in der Terminvergabe.<sup style="line-height:0;">1,</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Erhebliche Zeitersparnis</b> beim Impfvorgang.<sup style="line-height:0;">1,3,</sup></li> <li style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><b>Reduzierung von Anwendungsfehlern</b> bei der Dosierung.<sup style="line-height:0;">1,3,</sup></li> </ul> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px"><img alt="" style="display:block;border:0;outline:none;text-decoration:none" src="https://www.deutschesapothekenportal.de/newsletter/2024q3/newsletter_2024-09-27_g1.jpg"></p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-bottom:0px;padding-left:20px;padding-top:20px"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:20px;letter-spacing:0;color:#555555;font-size:14px">Bitte konsultieren Sie vor der Verabreichung die <b>Spikevax<sup style="line-height:0;">®</sup> JN.1</b> Fachinformation:</p> </td> </tr> <tr> <td align="center" style="Margin:0; padding: 20px 20px 20px 20px;"> <table role="presentation" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td align="center" style="border-radius: 0px;" bgcolor="#005CA9"> <a href="https://track.adform.net/C/?bn=76326168" target="_blank" style="font-size: 14px; font-family: Open Sans, Helvetica, Arial, sans-serif; color: #ffffff; text-decoration: none;background-color: #005CA9; padding: 10px 20px; border: 1px solid #005CA9; display: block;">Zur Fachinformation<br></a> </td> </tr> </tbody> </table> </td> </tr> <tr> <td align="center" style="padding:0;Margin:0;padding-left:20px;padding-right:20px; font-size:0"> <table border="0" width="100%" height="100%" cellpadding="0" cellspacing="0" class="es-spacer" role="presentation" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td style="padding:0;Margin:0;border-bottom:1px solid #b0b0b0;background:none;height:1px;width:100%;margin:0"></td> </tr> </tbody> </table> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:10px;padding-bottom:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px"># Nach Entnahme aus der Kühlung<br> Eine Impfdosis pro Fertigspritze </p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:5px;padding-bottom:10px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px"> <b>Referenzen:</b><br> 1 Fachinformation Spikevax<sup style="line-height:0;">®</sup> JN.1 [Internet]. 2024 [zitiert 11. September 2024]. Verfügbar unter: <a href="https://assets.modernatx.com/spikevax-jn.1-smpc-de.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;color:#005CA9;word-break:break-all;">https://assets.modernatx.com/spikevax-jn.1-smpc-de.pdf</a><br> 2 Robert Koch-Institut (RKI). Epidemiologisches Bulletin 02/2024 [Internet]. 2024 [zitiert 28. August 2024]. Verfügbar unter: <a href="https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/02_24.pdf?__blob=publicationFile" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;color:#005CA9;word-break:break-all;">https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/02_24.pdf?__blob=publicationFile</a><br> 3 Eijsink JFH, Weiss M, Taneja A, et al. Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting. Eur J Hosp Pharm. 27.06.2023 [zitiert 28. August 2024]. Verfügbar unter: <a href="https://ejhp.bmj.com/content/ejhpharm/early/2023/06/27/ejhpharm-2022-003620.full.pdf" target="_blank" style="mso-line-height-rule:exactly;text-decoration:none;color:#005CA9;word-break:break-all;">https://ejhp.bmj.com/content/ejhpharm/early/2023/06/27/ejhpharm-2022-003620.full.pdf</a> </p> </td> </tr> <tr> <td align="left" style="Margin:0;padding-right:20px;padding-left:20px;padding-top:5px;padding-bottom:25px;"> <p style="Margin:0;mso-line-height-rule:exactly;font-family:helvetica, 'helvetica neue', arial, verdana, sans-serif;line-height:13px;letter-spacing:0;color:#555555;font-size:11px">DE-COV-2400036</p> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>

Newsletter 2023

2024-10-07

Beitrag per e-mail verschicken

Auswertungsvorlage anzeigen

Statistik anzeigen